Scientific publications

Relation of left ventricular function, mass, and volume to NT-proBNP in type 1 diabetic patients

Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures

Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE (TM)

Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): Association with clinical characteristics, beta cell function and cardio-metabolic risk factors

Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes

Short-term reproducibility of impaired fasting glycaemia impaired glucose tolerance and diabetes The ADDITION study, DK

Glycaemic control and hypoglycaemia in the PRESENT study

Lessons in initiating insulin in clinical practice

Intensification lessons with modern premixes: From clinical trial to clinical practice

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double- blind, randomized, controlled trial in Japanese patients with type 2 diabetes

The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region

Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia

Patient acceptance and issues of education of two durable insulin pen devices

Evaluation of treatment satisfaction associated with the use of insulin aspart in continuous subcutaneous insulin infusion

Insulin treatment in diabetic pregnancy